Related Experiment Video
Updated: Aug 17, 2026

The Nematode Caenorhabditis Elegans - A Versatile In Vivo Model to Study Host-microbe Interactions
Published on: October 18, 2017
Efficacy testing of antimycotic prophylactics in an animal model
A Treiber1, W Pittermann, H C Schuppe
1Universitätsklinikum Düsseldorf, Tierversuchsanlage, Moorenstrasse 5, D-40225 Düsseldorf, Germany. treiber@uni-duesseldorf.de
Abstract:
Trichophyton mentagrophytes is both zoophilic and a common causative organism in human dermatomycosis. Therefore this dermatophyte is widely used for experimental efficacy testing of antimycotic agents and their active ingredients. The use of the guinea pig as an animal model for dermatomycosis is based on the predisposition of this species to spontaneous dermal fungal infections. A previously described guinea pig model was modified according to the results of pilot experiments. The modification consists of 1) evaluation of the infectious activity of the primary mycotic tissue cultures obtained from patients and 2) the efficacy testing itself with treatment of the infected skin area including the continuous clinical observation for 28 days. At first the required duration of cultivation and the number of spores for a reproducible infection of all animals were determined. The following efficacy test consisted of four groups with ten animals each. Group I (control of infection) remained without further treatment after experimental infections, groups II-IV received a single treatment by spraying at the day of infection with isopropanol (70%) (negative control), water (mechanic control) and the antimycotic agent (treated group), respectively. After 28 days under continuous examination, clinical symptoms (scabs; reddening, scaliness) were statistically analyzed. The model takes into account the duration and severity of infection in order to evaluate the differences between the four groups. The experimental protocol presented allows the efficacy of antimycotic agents to be demonstrated by means of statistical analyses. As an example the results of a successful prophylactic treatment against T. mentagrophytes with the antimycotic prophylactic Laudamonium (1%) are presented.
Insights
This study refines a guinea pig model for testing antifungal drugs against Trichophyton mentagrophytes, a common cause of human skin infections. The improved model allows for statistical analysis of treatment efficacy.
Area of Science:
- Mycology
- Dermatology
- Pharmacology
Background:
- Trichophyton mentagrophytes is a significant zoophilic dermatophyte causing human dermatomycosis.
- Guinea pigs are a suitable animal model for dermatomycosis due to their susceptibility to spontaneous fungal infections.
- Existing models require refinement for reproducible and statistically valid efficacy testing of antimycotic agents.
Purpose of the Study:
- To modify and validate a guinea pig model for assessing the efficacy of antimycotic agents against Trichophyton mentagrophytes.
- To establish standardized methods for infection induction and clinical observation.
- To enable statistically sound evaluation of treatment outcomes.
Main Methods:
- Modification of a previously described guinea pig model.
- Infection of animals with primary mycotic tissue cultures of T. mentagrophytes.
- Treatment groups included infection control, negative control (isopropanol), mechanical control (water), and antimycotic agent.
- 28-day continuous clinical observation and statistical analysis of symptoms (scabs, redness, scaliness).
Main Results:
- The modified protocol determined optimal cultivation duration and spore counts for reproducible infection.
- Statistical analysis of clinical symptoms demonstrated significant differences between treatment groups.
- The model successfully evaluated the prophylactic efficacy of Laudamonium (1%) against T. mentagrophytes.
Conclusions:
- The presented experimental protocol provides a statistically valid method for demonstrating the efficacy of antimycotic agents.
- The refined guinea pig model is effective for screening and validating new antifungal treatments.
- This model aids in the development of new therapies for dermatomycosis caused by T. mentagrophytes.
Related Concept Videos
Toxicity Testing in Animals
Antimicrobial Effectiveness

